New technologies are rapidly reshaping health care. However, their effect on drug development to date generally has been limited.
To evaluate disease modeling and simulation, alternative study design, novel objective measures, virtual research visits, and enhanced participant engagement and to examine their potential effects ...
JAMA Neurol. Published online March 02, 2015. doi:10.1001/jamaneurol.2014.4524